Lijie Pan

1.2k total citations
39 papers, 824 citations indexed

About

Lijie Pan is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lijie Pan has authored 39 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Lijie Pan's work include RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Liver physiology and pathology (3 papers). Lijie Pan is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Liver physiology and pathology (3 papers). Lijie Pan collaborates with scholars based in China and United States. Lijie Pan's co-authors include Qi Zhang, Yan Xu, Zhenya Zhang, Xinyi Wu, Bin Wang, Beibei Ni, Mian Ge, Li Pan, Zongming Zhang and Shuai Dong and has published in prestigious journals such as Nature Communications, Biomaterials and Hepatology.

In The Last Decade

Lijie Pan

37 papers receiving 815 citations

Peers

Lijie Pan

ONCOL

IMMUN

Zhe Lin China

Jiang Chen China

Jianhua Wang China

Toshiyuki Takehara Japan

Xiangyu Wang China

Zixi Wang China

Zhangfa Song China

Jing Bai China

David Ivancic United States

Zhe Lin China

Lijie Pan

366 ×0.9

132 ×0.9

108 ×1.0

ONCOL

120 ×1.3

IMMUN

71 ×0.8

Citations per year, relative to Lijie Pan Lijie Pan (= 1×) peers Zhe Lin

Countries citing papers authored by Lijie Pan

Since Specialization

Citations

This map shows the geographic impact of Lijie Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Pan more than expected).

Fields of papers citing papers by Lijie Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijie Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Pan. The network helps show where Lijie Pan may publish in the future.

Co-authorship network of co-authors of Lijie Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lijie Pan. A scholar is included among the top collaborators of Lijie Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie Pan. Lijie Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Bo, Haibo Li, Zhan‐Cheng Zeng, et al.. (2025). METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response. FEBS Open Bio. 15(7). 1144–1158.

Shao, Xinxin, Yuandi Xi, Lijie Pan, et al.. (2024). The effectiveness of Tai Chi for patients with mild cognitive impairment: a systematic review and meta−analysis. Frontiers in Neuroscience. 18. 1467595–1467595. 3 indexed citations

Liu, Xiao, Yan Xu, Lijie Pan, et al.. (2023). m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury. Hepatology. 81(1). 94–110. 10 indexed citations

Cheng, Yusheng, Yihang Gong, Xiuxing Chen, et al.. (2022). Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma. Biomaterials. 284. 121506–121506. 77 indexed citations

Gong, Yihang, Wen-Jie Chen, Xiuxing Chen, et al.. (2022). An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer. Advanced Science. 9(23). e2201271–e2201271. 42 indexed citations

Xu, Yan, Lijie Pan, Chang Liu, et al.. (2022). Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a. Nature Communications. 13(1). 4555–4555. 46 indexed citations

Pan, Lijie, et al.. (2022). Deletion of Mettl3 at the Pro-B Stage Marginally Affects B Cell Development and Profibrogenic Activity of B Cells in Liver Fibrosis. Journal of Immunology Research. 2022. 1–17. 9 indexed citations

Li, Yanli, Lijie Pan, Huaxin Chen, et al.. (2022). The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. Molecular Therapy. 30(12). 3714–3728. 41 indexed citations

Shen, Lin, et al.. (2022). The role of Wnt/β-catenin pathway for skin-derived precursors differentiating into corneal endothelial cell-like cells. Experimental Eye Research. 218. 109008–109008. 2 indexed citations

10.

Pan, Lijie, et al.. (2022). Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China. Frontiers in Medicine. 8. 823346–823346. 20 indexed citations

11.

Gong, Li‐ping, Lijie Pan, Zhiying Feng, et al.. (2022). ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3. Cancer Letters. 535. 215646–215646. 28 indexed citations

12.

Zhu, Shuyan, Jianqiao Li, Lijie Pan, et al.. (2022). Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis. Frontiers in Pharmacology. 13. 996635–996635. 3 indexed citations

13.

Jiang, Nan, Tian Tian, Xianyang Chen, et al.. (2021). A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps. Journal of Oncology. 2021. 1–10. 5 indexed citations

14.

Liu, Qiuli, Xiaoyong Chen, Chang Liu, et al.. (2021). Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Cell Death and Disease. 12(3). 240–240. 26 indexed citations

15.

Pan, Lijie, Chang Liu, Qiuli Liu, et al.. (2021). Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis. Stem Cell Research & Therapy. 12(1). 496–496. 21 indexed citations

16.

Li, Xuejie, et al.. (2021). CRISPR/dCas9-mediated epigenetic modification reveals differential regulation of histone acetylation on Aspergillus niger secondary metabolite. Microbiological Research. 245. 126694–126694. 33 indexed citations

17.

Chen, Huaxin, Jianye Cai, Jiancheng Wang, et al.. (2020). Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation. Journal of Hepatology. 74(5). 1176–1187. 52 indexed citations

18.

Jiang, Nan, Lijie Pan, Liwei Zhang, et al.. (2017). Potential plasma lipid biomarkers in early-stage breast cancer. Biotechnology Letters. 39(11). 1657–1666. 27 indexed citations

19.

Li, Xueling, Hong Cao, Biao Di, et al.. (2012). Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice. Microbes and Infection. 14(11). 1000–1007. 21 indexed citations

20.

Pan, Lijie, et al.. (2009). Construction of human TRPC1 eukaryotic expression vector and its expression in HL-7702 cells. Zhonghua shiyan waike zazhi. 26(8). 976–978. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact